Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIradimed Corp Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.44 | $0.45 | $0.45 |
| Q2 2026 | 1 | $0.42 | $0.46 | $0.44 |
| Q3 2026 | 1 | $0.53 | $0.55 | $0.54 |
| Q4 2026 | 1 | $0.60 | $0.61 | $0.61 |
| Q1 2027 | 1 | $0.58 | $0.60 | $0.59 |
| Q2 2027 | 1 | $0.53 | $0.55 | $0.54 |
| Q3 2027 | 1 | $0.58 | $0.60 | $0.59 |
| Q4 2027 | 1 | $0.61 | $0.63 | $0.62 |
Iradimed Corp Earnings Date And Information
Iradimed Corp last posted its earnings results on Friday, May 1st, 2026. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.07. The company had revenue of 21.98 M for the quarter and had revenue of 83.81 M for the year. Iradimed Corp has generated $2 earnings per share over the last year ($1.75 diluted earnings per share) and currently has a price-to-earnings ratio of 46.17. Iradimed Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Iradimed Corp Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/01/2026 | Q1 2026 | $0.42 | $0.46 | 0.04 | $21.32 M | $21.98 M |
| 03/06/2026 | Q4 2025 | N/A | $0.51 | N/A | $21.60 M | $22.69 M |
| 11/03/2025 | Q3 2025 | $0.48 | $0.44 | -0.04 | $20.50 M | $21.20 M |
| 08/01/2025 | Q2 2025 | $0.45 | $0.45 | 0 | $20.01 M | $20.41 M |
| 05/05/2025 | Q1 2025 | $0.43 | $0.37 | -0.06 | $19.33 M | $19.51 M |
| 03/06/2025 | Q4 2024 | N/A | $0.41 | N/A | $19.10 M | $19.39 M |
| 10/31/2024 | Q3 2024 | $0.39 | $0.40 | 0.01 | $18.15 M | $18.33 M |
| 08/01/2024 | Q2 2024 | $0.37 | $0.39 | 0.02 | $17.65 M | $17.93 M |
| 05/02/2024 | Q1 2024 | $0.34 | $0.33 | -0.01 | $17.15 M | $17.60 M |
| 03/01/2024 | Q4 2023 | N/A | $0.36 | N/A | N/A | $17.45 M |
| 11/03/2023 | Q3 2023 | $0.36 | $0.40 | 0.04 | N/A | $16.50 M |
| 08/03/2023 | Q2 2023 | $0.31 | $0.33 | 0.02 | N/A | $16.13 M |
| 05/04/2023 | Q1 2023 | $0.28 | $0.27 | -0.01 | N/A | $15.48 M |
| 03/02/2023 | Q4 2022 | N/A | $0.29 | N/A | N/A | $14.86 M |
| 11/03/2022 | Q3 2022 | $0.25 | $0.27 | 0.02 | N/A | $13.41 M |
| 08/05/2022 | Q2 2022 | N/A | $0.26 | N/A | N/A | $12.72 M |
| 05/06/2022 | Q1 2022 | N/A | $0.20 | N/A | N/A | $12.31 M |
| 03/04/2022 | Q4 2021 | N/A | $0.31 | N/A | N/A | $11.87 M |
| 11/05/2021 | Q3 2021 | N/A | $0.21 | N/A | N/A | $10.91 M |
| 08/06/2021 | Q2 2021 | N/A | $0.12 | N/A | N/A | $9.81 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Iradimed Corp Earnings: FAQ's
In the previous quarter, Iradimed Corp (:IRMD) reported $0.49 earnings per share (EPS) to beat the analysts' consensus estimate of $0.42 by $0.07.
The conference call for Iradimed Corp's latest earnings report can be listened to online.
The conference call transcript for Iradimed Corp's latest earnings report can be read online.
Iradimed Corp (:IRMD) has a recorded annual revenue of $83.81 M.
Iradimed Corp (:IRMD) has a recorded net income of $22.48 M.Iradimed Corp has generated $1.77 earnings per share over the last four quarters.
Iradimed Corp (:IRMD) has a price-to-earnings ratio of 46.17 and price/earnings-to-growth ratio is 2.5.